We aim to create value by providing talented entrepreneurs with the resources and tools to achieve success in transforming intellectual capital and specific knowledge into successful companies



Ysios news
23.04.14
Kala Pharmaceuticals Announces $22.5 Million Series B Financing

19.03.14
Ysios Capital begins fundraising for Ysios Biofund II

portfolio news
23.04.14
Kala Pharmaceuticals Announces $22.5 Million Series B Financing

03.04.14
TiGenix licenses exclusive marketing and distribution rights for ChondroCelect to Sobi